Siemoneit Ulf, Tausch Lars, Poeckel Daniel, Paul Michael, Northoff Hinnak, Koeberle Andreas, Jauch Johann, Werz Oliver
Department of Pharmaceutical Analytics, Pharmaceutical Institute, Eberhard Karls University Tuebingen, Tuebingen, Germany.
Institute of Pharmaceutical Chemistry, University of Frankfurt, Frankfurt, Germany.
Planta Med. 2017 Aug;83(12-13):1020-1027. doi: 10.1055/s-0043-107884. Epub 2017 Apr 12.
Boswellic acids constitute a group of unique pentacyclic triterpene acids from with multiple pharmacological activities that confer them anti-inflammatory and anti-tumoral properties. A subgroup of boswellic acids, characterized by an 11-keto group, elevates intracellular Ca concentrations [Ca] and causes moderate aggregation of human platelets. How different BAs and their mixtures in pharmacological preparations affect these parameters in activated platelets has not been addressed, so far. Here, we show that boswellic acids either antagonize or induce Ca mobilization and platelet aggregation depending on defined structural determinants with inductive effects predominating for a gum resin extract. 3--Acetyl-11-keto--boswellic acid potently suppressed Ca mobilization (IC = 6 µM) and aggregation (IC = 1 µM) when platelets were activated by collagen or the thromboxane A receptor agonist U-46619, but not upon thrombin. In contrast, -boswellic acid and 3--acetyl--boswellic acid, which lack the 11-keto moiety, were weak inhibitors of agonist-induced platelet responses, but instead they elicited elevation of [Ca] and aggregation of platelets (≥ 3 µM). 11-Keto--boswellic acid, the structural intermediate between 3--acetyl-11-keto--boswellic acid and -boswellic acid, was essentially inactive independent of the experimental conditions. Together, our study unravels the complex agonizing and antagonizing properties of boswellic acids on human platelets in pharmacologically relevant preparations of gum extracts and prompts for careful evaluation of the safety of such extracts as herbal medicine in cardiovascular risk patients.
乳香酸是一类独特的五环三萜酸,具有多种药理活性,赋予它们抗炎和抗肿瘤特性。乳香酸的一个亚组,其特征在于具有11-酮基,可提高细胞内钙浓度[Ca]并导致人血小板适度聚集。到目前为止,乳香酸及其在药理制剂中的混合物如何影响活化血小板中的这些参数尚未得到解决。在这里,我们表明,乳香酸根据确定的结构决定因素拮抗或诱导钙动员和血小板聚集,对于一种树胶树脂提取物,诱导作用占主导。当血小板被胶原蛋白或血栓素A受体激动剂U-46619激活时,3-乙酰基-11-酮基-β-乳香酸有效抑制钙动员(IC = 6 μM)和聚集(IC = 1 μM),但对凝血酶无此作用。相比之下,缺乏11-酮基部分的β-乳香酸和3-乙酰基-β-乳香酸是激动剂诱导的血小板反应的弱抑制剂,但它们反而引起[Ca]升高和血小板聚集(≥3 μM)。11-酮基-β-乳香酸是3-乙酰基-11-酮基-β-乳香酸和β-乳香酸之间的结构中间体,无论实验条件如何,基本上都没有活性。总之,我们的研究揭示了在药理相关的树胶提取物制剂中,乳香酸对人血小板具有复杂的激动和拮抗特性,并促使人们仔细评估此类提取物作为心血管风险患者草药的安全性。